Editorial in response to Thangaiah et al.
Cancer Cytopathology · 2023-06 · 131 (6) · 349-350
DOI: 10.1002/cncy.22689 ↗Kurz gefasst
Editorial in der Zeitschrift Cancer Cytopathology, online erschienen am 01.03.2023. Verfasst von M Lisa Zhang. Beteiligte Einrichtung: Department of Pathology, Massachusetts General Hospital, Boston, Massachusetts, USA. Die Arbeit nennt 5 Literaturangaben.
Abstract (Originalsprache)
In the April 2023 issue, Thangaiah and colleagues have revisited the infrequently studied but important topic of distinguishing autoimmune pancreatitis from well‐differentiated (and sometimes moderately differentiated) pancreatic ductal adenocarcinoma. This distinction is crucial because of the important implications for patient management.
Autor:innen und Institutionen
- Department of Pathology, Massachusetts General Hospital, Boston, Massachusetts, USA.
- Harvard Medical School, Boston, Massachusetts, USA.
Zitieren
APA
Zhang, M. L. (2023). Editorial in response to Thangaiah et al. Cancer Cytopathology, 131(6), 349-350. https://doi.org/10.1002/cncy.22689
Vancouver
Zhang ML. Editorial in response to Thangaiah et al. Cancer Cytopathology. 2023;131(6):349-350. doi:10.1002/cncy.22689
BibTeX
@article{Zhang2023,
author = {Zhang, M Lisa},
title = {Editorial in response to Thangaiah et al},
journal = {Cancer Cytopathology},
year = {2023},
volume = {131},
number = {6},
pages = {349--350},
doi = {10.1002/cncy.22689}
}
EUVIMED